2015 Q4 Form 10-Q Financial Statement

#000119312515368422 Filed on November 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $3.313M $1.459M $120.0K
YoY Change 1048.33% 1115.08% -97.84%
Cost Of Revenue $200.0K $873.5K $27.03K
YoY Change 400.0% 3132.14% -84.06%
Gross Profit $3.116M $585.1K $93.02K
YoY Change 1167.27% 529.04% -98.27%
Gross Profit Margin 94.07% 40.11% 77.49%
Selling, General & Admin $5.330M $2.630M $2.782M
YoY Change -12.91% -5.47% -40.42%
% of Gross Profit 171.03% 449.48% 2991.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $330.0K $340.0K $2.470M
YoY Change -80.7% -86.23% 394.0%
% of Gross Profit 10.59% 58.11% 2655.34%
Operating Expenses $5.320M $5.810M $7.924M
YoY Change -13.07% -26.68% -11.95%
Operating Profit -$2.204M -$4.351M -$7.804M
YoY Change -62.49% -44.25% 126.54%
Interest Expense -$2.580M $1.207M $268.9K
YoY Change 760.0% 348.75% -69.93%
% of Operating Profit
Other Income/Expense, Net $410.0K -$1.223M $130.0K
YoY Change -4200.0% -1040.99% 36.23%
Pretax Income $1.230M -$5.574M -$7.674M
YoY Change -119.87% -27.36% 129.12%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $2.214M -$4.580M -$7.415M
YoY Change -142.22% -38.23% 106.86%
Net Earnings / Revenue 66.83% -314.01% -6176.9%
Basic Earnings Per Share -$0.60 -$0.09
Diluted Earnings Per Share $295.1K -$0.60 -$0.09
COMMON SHARES
Basic Shares Outstanding 89.80M shares 7.482M shares 85.27M shares
Diluted Shares Outstanding 7.482M shares 85.27M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.240M $1.840M $3.710M
YoY Change -28.66% -50.4% -66.79%
Cash & Equivalents $2.241M $1.840M $3.712M
Short-Term Investments
Other Short-Term Assets $502.7K $495.3K $598.3K
YoY Change -23.33% -17.22% -48.72%
Inventory $0.00 $335.0K $676.4K
Prepaid Expenses $497.1K
Receivables $801.6K $596.8K $6.420M
Other Receivables $50.00K
Total Short-Term Assets $3.546M $3.480M $12.07M
YoY Change -69.09% -71.17% -39.42%
LONG-TERM ASSETS
Property, Plant & Equipment $2.827M $5.305M $8.806M
YoY Change -60.93% -39.75% -3.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $540.6K $1.008M $1.290M
YoY Change -57.5% -21.85% 1.68%
Total Long-Term Assets $3.367M $17.08M $15.23M
YoY Change -75.27% 12.19% -2.29%
TOTAL ASSETS
Total Short-Term Assets $3.546M $3.480M $12.07M
Total Long-Term Assets $3.367M $17.08M $15.23M
Total Assets $6.913M $20.56M $27.30M
YoY Change -72.45% -24.68% -23.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.568M $2.425M $3.832M
YoY Change -69.09% -36.71% 58.96%
Accrued Expenses $4.265M $3.690M $3.213M
YoY Change 78.62% 14.85% -27.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $15.06M $30.78M $9.360M
YoY Change 60.9% 228.85% -55.06%
Total Short-Term Liabilities $24.68M $39.76M $19.37M
YoY Change 29.59% 105.23% -42.4%
LONG-TERM LIABILITIES
Long-Term Debt $3.140M $4.390M $7.980M
YoY Change -73.41% -44.99% 369.41%
Other Long-Term Liabilities $4.640M $4.640M $4.640M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $7.785M $9.029M $12.62M
YoY Change -52.68% -28.48% 98.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.68M $39.76M $19.37M
Total Long-Term Liabilities $7.785M $9.029M $12.62M
Total Liabilities $32.46M $48.79M $32.00M
YoY Change -8.54% 52.48% -19.96%
SHAREHOLDERS EQUITY
Retained Earnings -$220.6M -$222.8M -$197.2M
YoY Change 8.99% 13.02% 5.61%
Common Stock $204.4M $203.0M $8.532K
YoY Change 3.08% 2379005.29% 4.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.20M -$19.86M -$4.701M
YoY Change
Total Liabilities & Shareholders Equity $6.913M $20.56M $27.30M
YoY Change -72.45% -24.68% -23.12%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $2.214M -$4.580M -$7.415M
YoY Change -142.22% -38.23% 106.86%
Depreciation, Depletion And Amortization $330.0K $340.0K $2.470M
YoY Change -80.7% -86.23% 394.0%
Cash From Operating Activities -$1.780M -$3.200M -$6.560M
YoY Change -67.81% -51.22% -20.58%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 -$180.0K
YoY Change -92.86% -100.0% -72.73%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$10.00K $0.00 -$180.0K
YoY Change -92.86% -100.0% -90.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.190M -580.0K 4.730M
YoY Change -57.06% -112.26% -57.04%
NET CHANGE
Cash From Operating Activities -1.780M -3.200M -6.560M
Cash From Investing Activities -10.00K 0.000 -180.0K
Cash From Financing Activities 2.190M -580.0K 4.730M
Net Change In Cash 400.0K -3.780M -2.010M
YoY Change -170.18% 88.06% -339.29%
FREE CASH FLOW
Cash From Operating Activities -$1.780M -$3.200M -$6.560M
Capital Expenditures -$10.00K $0.00 -$180.0K
Free Cash Flow -$1.770M -$3.200M -$6.380M
YoY Change -67.16% -49.84% -16.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 omex Number Of Securities Called By Warrants Or Rights Upon Additional Financing
NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing
434027 shares
CY2012Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.60
CY2012Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
8000000
CY2012Q2 omex Number Of Securities Called By Warrants Or Rights Upon Additional Financing
NumberOfSecuritiesCalledByWarrantsOrRightsUponAdditionalFinancing
434027 shares
CY2012Q2 omex Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
260417 shares
CY2015Q1 omex Common Stock Minimum Bid Price
CommonStockMinimumBidPrice
1.00
CY2010Q4 omex Class Of Warrant Or Right Warrants Issued
ClassOfWarrantOrRightWarrantsIssued
1800000 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.60
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3711573
CY2015Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.60
CY2015Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
4737104 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89796469 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9567600 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89796469 shares
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
251023
CY2015Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9029303
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
202976283
CY2015Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3687821
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4631593
CY2015Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2482190
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
-19862934
CY2015Q3 us-gaap Deferred Revenue
DeferredRevenue
5026898
CY2015Q3 us-gaap Loans Payable Current
LoansPayableCurrent
30783245
CY2015Q3 us-gaap Bank Loans
BankLoans
11800000
CY2015Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
383148
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2425425
CY2015Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
4385553
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-222848197
CY2015Q3 us-gaap Liabilities
Liabilities
48791132
CY2015Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
9955000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1008019
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20561993
CY2015Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4643750
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
8980
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-28229139
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22778808
CY2015Q3 us-gaap Minority Interest
MinorityInterest
-8366205
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
39761829
CY2015Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
66695223
CY2015Q3 us-gaap Assets
Assets
20561993
CY2015Q3 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
3567722
CY2015Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
4478595
CY2015Q3 us-gaap Inventory Net
InventoryNet
335013
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
596781
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5305295
CY2015Q3 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
279959
CY2015Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
6887246
CY2015Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
383148
CY2015Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
56236
CY2015Q3 us-gaap Assets Current
AssetsCurrent
3479619
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
495308
CY2015Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1776272
CY2015Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
6290465
CY2015Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
196381
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
212116
CY2015Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
24320000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1840401
CY2015Q3 omex Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
4813608
CY2015Q3 omex Mortgage And Loans Payable Current And Non Current
MortgageAndLoansPayableCurrentAndNonCurrent
35168798
CY2015Q3 omex Maximum Issue Of Warrants To Purchase Common Stock
MaximumIssueOfWarrantsToPurchaseCommonStock
1302083 shares
CY2015Q3 omex Noncurrent Assets Excluding Property Plant And Equipment
NoncurrentAssetsExcludingPropertyPlantAndEquipment
11777079
CY2015Q3 omex Fair Value Assumptions Quoted Price
FairValueAssumptionsQuotedPrice
2.5
CY2015Q3 omex Revenue Participation Agreement Value
RevenueParticipationAgreementValue
15000000
CY2015Q3 omex Retail Related Recovered Cargo
RetailRelatedRecoveredCargo
4728436
CY2015Q3 omex Working Capital Deficit
WorkingCapitalDeficit
36300000
CY2015Q3 omex Convertible Notes Payable Outstanding
ConvertibleNotesPayableOutstanding
14750000
CY2015Q3 omex Number Of Bank Loans Cross Collateralized
NumberOfBankLoansCrossCollateralized
3 Loans
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
371332
CY2014Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
16451907
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
198323630
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2387962
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4631593
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2226445
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-4095061
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
4643750
CY2014Q4 us-gaap Loans Payable Current
LoansPayableCurrent
9356724
CY2014Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
89796469 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21322257
CY2014Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
4737104 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85582502 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
9567600 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85582502 shares
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5070973
CY2014Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
11808157
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202427252
CY2014Q4 us-gaap Liabilities
Liabilities
35494011
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25089539
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4643750
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
8558
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10404472
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22443492
CY2014Q4 us-gaap Minority Interest
MinorityInterest
-6309411
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19042104
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60312726
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1272053
CY2014Q4 us-gaap Assets
Assets
25089539
CY2014Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
1024999
CY2014Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
5110967
CY2014Q4 us-gaap Inventory Net
InventoryNet
674992
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6476049
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7235538
CY2014Q4 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
405467
CY2014Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6476049
CY2014Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
70560
CY2014Q4 us-gaap Assets Current
AssetsCurrent
11470981
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
655662
CY2014Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
3758688
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
520728
CY2014Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
24895343
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3143550
CY2014Q4 omex Inventory Current And Non Current Net
InventoryCurrentAndNonCurrentNet
5785959
CY2014Q4 omex Mortgage And Loans Payable Current And Non Current
MortgageAndLoansPayableCurrentAndNonCurrent
21164881
CY2014Q4 omex Noncurrent Assets Excluding Property Plant And Equipment
NoncurrentAssetsExcludingPropertyPlantAndEquipment
6383020
CY2014Q4 omex Retail Related Recovered Cargo
RetailRelatedRecoveredCargo
5681264
CY2015Q1 omex Number Of Periods Afforded To Regain Compliance With Minimum Bid Price
NumberOfPeriodsAffordedToRegainComplianceWithMinimumBidPrice
P180D
CY2015Q1 omex Number Of Consecutive Business Periods Not Complied With Minimum Bid Price
NumberOfConsecutiveBusinessPeriodsNotCompliedWithMinimumBidPrice
P30D
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-23023052
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
1.69
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84707367 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84707367 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2830198
us-gaap Net Income Loss
NetIncomeLoss
-21229763
us-gaap Revenues
Revenues
1034396
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
676820
us-gaap Interest Paid
InterestPaid
648547
us-gaap Profit Loss
ProfitLoss
-22476929
us-gaap Operating Income Loss
OperatingIncomeLoss
-22319219
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
25194
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
286534
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2043110
us-gaap Income Taxes Paid
IncomeTaxesPaid
15000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
113540
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-638765
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6213432
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
982912
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
676820
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2347826
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-522500
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22957984
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-481055
us-gaap Share Based Compensation
ShareBasedCompensation
1785306
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17610684
us-gaap Operating Expenses
OperatingExpenses
23353615
us-gaap Interest Expense
InterestExpense
931819
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2830198
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
8242566
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1750527
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
12684514
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1827767
us-gaap Transfer To Investments
TransferToInvestments
522500
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15046
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8191210
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
302744
us-gaap Cost Of Goods Sold
CostOfGoodsSold
204516
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
359400
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3802547
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1247166
omex Reversal Of Bad Debt Provision
ReversalOfBadDebtProvision
522500
omex Operations And Research
OperationsAndResearch
14957889
omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-21229763
omex Exhibit Revenue
ExhibitRevenue
51484
omex Senior Convertible Debit Interest Settled With Common Stock Issuance
SeniorConvertibleDebitInterestSettledWithCommonStockIssuance
73037
omex Prior Period Accrued Compensation Paid By Equity Instruments
PriorPeriodAccruedCompensationPaidByEquityInstruments
113126
omex Repayment Of Mortgage And Loans Payable
RepaymentOfMortgageAndLoansPayable
14463332
omex Proceeds From Payment For Restricted Cash Held As Collateral On Loan Payable
ProceedsFromPaymentForRestrictedCashHeldAsCollateralOnLoanPayable
10021384
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15380090
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.58
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000798528
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.000 pure
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-6
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2015-08-31
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
ODYSSEY MARINE EXPLORATION INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88655418 shares
us-gaap Accelerated Share Repurchases Initial Price Paid Per Share
AcceleratedShareRepurchasesInitialPricePaidPerShare
4.32
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88655418 shares
us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2014-04-13
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Management used estimates and assumptions in preparing these financial statements in accordance with generally accepted accounting principles. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used.</p> </div>
dei Trading Symbol
TradingSymbol
OMEX
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42828
us-gaap Net Income Loss
NetIncomeLoss
-20420945
us-gaap Revenues
Revenues
2017487
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-255745
us-gaap Interest Paid
InterestPaid
1098719
us-gaap Profit Loss
ProfitLoss
-22477739
us-gaap Operating Income Loss
OperatingIncomeLoss
-19310911
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
122
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-972352
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-272467
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
2000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22819
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3166828
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-6382497
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
253347
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
411197
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
-29404
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
45000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
246653
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1250982
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
500000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1689968
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-255745
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22477739
us-gaap Share Based Compensation
ShareBasedCompensation
2135071
us-gaap Proceeds From Derivative Instrument Financing Activities
ProceedsFromDerivativeInstrumentFinancingActivities
10000000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1303149
us-gaap Operating Expenses
OperatingExpenses
21328398
us-gaap Interest Expense
InterestExpense
2888386
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
805172
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
13271769
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
850000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1446662
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
14750001
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
607106
us-gaap Inventory Write Down
InventoryWriteDown
151922
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
383148
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9000307
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1277024
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2645548
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1093747
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2056794
omex Percentage Of Subsequent Cash Proceeds After Reimbursement
PercentageOfSubsequentCashProceedsAfterReimbursement
0.45 pure
omex Common Stock Warrants Expiration Period
CommonStockWarrantsExpirationPeriod
P5Y
omex Borrowing Base Value Of Secured Collateral Percentage
BorrowingBaseValueOfSecuredCollateralPercentage
0.40 pure
omex Percentage Of Conversion Price Of Quoted Market Prices
PercentageOfConversionPriceOfQuotedMarketPrices
0.75 pure
omex Percentage Of Cash Proceeds From Monetization Of Recovered Cargo
PercentageOfCashProceedsFromMonetizationOfRecoveredCargo
0.80 pure
CY2015Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
omex Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
Three months or less
omex Period For Registration Statement Subject To Review
PeriodForRegistrationStatementSubjectToReview
120 days thereafter
omex Expedition Charter Revenue
ExpeditionCharterRevenue
281667
omex Operations And Research
OperationsAndResearch
8557109
omex Estimated Annual Effective Tax Rate
EstimatedAnnualEffectiveTaxRate
0.3125 pure
omex Common Stock Issued For Subsidiary Stock Option Settlement
CommonStockIssuedForSubsidiaryStockOptionSettlement
2520000
omex Shares Of Common Stock Issuable Upon Exercise Of Warrant
SharesOfCommonStockIssuableUponExerciseOfWarrant
434027 shares
omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-20420945
omex Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan
omex Share Repurchase Agreement Expiration Date
ShareRepurchaseAgreementExpirationDate
2016-03-30
omex Exhibit Revenue
ExhibitRevenue
45852
omex Period For Warrant Term
PeriodForWarrantTerm
P5Y6M
omex Debt Instrument Revised Maturity Date
DebtInstrumentRevisedMaturityDate
2015-12-17
omex Period For Registration Statement Of Initial Closing Date
PeriodForRegistrationStatementOfInitialClosingDate
P6M
omex Percentage Of Debt Instrument Conversion Price On Market Price Of Common Stock
PercentageOfDebtInstrumentConversionPriceOnMarketPriceOfCommonStock
1.250 pure
omex Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
21700000
omex Percentage Of Acceleration Payment Of Remaining Face Value
PercentageOfAccelerationPaymentOfRemainingFaceValue
1.25 pure
omex Number Of Financial Institutions In Which Cash Deposited
NumberOfFinancialInstitutionsInWhichCashDeposited
1 Institution
omex Period For Registration Statement To Be Declared Effective
PeriodForRegistrationStatementToBeDeclaredEffective
90 days thereafter
omex Secured Collateral
SecuredCollateral
21962 Coins
omex Repayment Of Mortgage And Loans Payable
RepaymentOfMortgageAndLoansPayable
1786844
omex Proceeds From Payment For Restricted Cash Held As Collateral On Loan Payable
ProceedsFromPaymentForRestrictedCashHeldAsCollateralOnLoanPayable
308612
omex Option Agreement Period Of Extension
OptionAgreementPeriodOfExtension
P2Y
omex Estimated Market Rate Loan Percentage
EstimatedMarketRateLoanPercentage
0.15 pure
CY2014Q3 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
1.22
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85271429 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85271429 shares
CY2014 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
6290465
CY2014Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
271606
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-7415124
CY2014Q3 us-gaap Revenues
Revenues
120046
CY2014Q3 us-gaap Profit Loss
ProfitLoss
-7673838
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7803841
CY2014Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
557
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
92497
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
130003
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
95046
CY2014Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
305841
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7673838
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
7923887
CY2014Q3 us-gaap Interest Expense
InterestExpense
268892
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1898111
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2782362
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
27026
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-258714
CY2014Q3 omex Operations And Research
OperationsAndResearch
5114499
CY2014Q3 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-7415124
CY2014Q3 omex Exhibit Revenue
ExhibitRevenue
25000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2015Q3 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.37
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89781577 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89781577 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-4580255
CY2015Q3 us-gaap Revenues
Revenues
1458653
CY2015Q3 us-gaap Profit Loss
ProfitLoss
-5574322
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4351011
CY2015Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
27
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11944
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1223311
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1368795
CY2015Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-4732
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5574322
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
5809664
CY2015Q3 us-gaap Interest Expense
InterestExpense
1206662
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
504732
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2630094
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
873517
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-994067
CY2015Q3 omex Expedition Charter Revenue
ExpeditionCharterRevenue
77358
CY2015Q3 omex Operations And Research
OperationsAndResearch
2306053
CY2015Q3 omex Bank Loan Maturity Period
BankLoanMaturityPeriod
2015
CY2015Q3 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-4580255
CY2015Q3 omex Exhibit Revenue
ExhibitRevenue
12500

Files In Submission

Name View Source Status
0001193125-15-368422-index-headers.html Edgar Link pending
0001193125-15-368422-index.html Edgar Link pending
0001193125-15-368422.txt Edgar Link pending
0001193125-15-368422-xbrl.zip Edgar Link pending
d51786d10q.htm Edgar Link pending
d51786dex101.htm Edgar Link pending
d51786dex311.htm Edgar Link pending
d51786dex312.htm Edgar Link pending
d51786dex321.htm Edgar Link pending
d51786dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g51786txpg2.jpg Edgar Link pending
omex-20150930.xml Edgar Link completed
omex-20150930.xsd Edgar Link pending
omex-20150930_cal.xml Edgar Link unprocessable
omex-20150930_def.xml Edgar Link unprocessable
omex-20150930_lab.xml Edgar Link unprocessable
omex-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending